Why Oric Pharmaceuticals ORIC might be early to something big Grinds Lower 20260506 What Power REIT PW is doing to earn customer loyalty 394 20260508 What Caterpillar CAT is doing that creates lasting advantage Q1 2026 Better Than Expected How Gladstone GLAD adapts when conditions change In Focus 20260505 Saratoga SAV Q1 2026 Results Miss Estimates EPS 016 vs 056 Cerebras IPO Surges as Tech Rally Lifts Wall Street Global Markets Advance as TrumpXi Summit Signals Strait of Hormuz Stability PHINIA PHIN Q1 2026 Earnings Surprise EPS 129 Up Significant Eicher Motors Reports Q4 Net Profit of 1520 Crore Announces 3400 Crore Investment Plan Tesla Launches Full SelfDriving Supervised in China Amid Surge of Domestic EV Competition US April Payrolls Surge Beyond Expectations Yet Red Flags Emerge ABB India Call Option and Delhivery Put Option Options Market Analysis 401k Millionaire Count Dips as Workers Boost Savings to Record Levels Fidelity Q1 Data Latin American Leaders Call for Housing Finance Overhaul and ClimateResilient Urban Development at WUF13 Waldencast WALD Q4 2024 Earnings Significant EPS Miss Reflects Persistent Operational Challenges Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters BLSH Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction FHN Q1 2026 Earnings EPS Beats Estimates by Over 6 Shares Edge Higher VCTR Q1 2026 Earnings EPS Beats Estimates Amid Strong Operating Performance Grove Collaborative Holdings GROV Inches Higher as Stock Hovers Near Resistance BranchOut Food Inc BOF Edges Higher as Stock Holds Above Key Support Level CNA Financial Stock Slips Slightly as Shares Trade Near Midpoint of Recent Range IGC Pharma Inc IGC Stabilizes Near Key Resistance After Modest Gain Amphastar Pharmaceuticals AMPH Gains 14 as Stock Tests Resistance Near 2034 Goldman Sachs PostEarnings Outlook Market Perception vs Financial Performance UHT Q1 2026 Earnings Realty Trust Posts Modest Profit Amid Flat Revenue Trends Qiagen QGEN Holds Steady Above 35 as Biotech Sector Gains Momentum